Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03815019 · ClinicalTrials.gov registry record · Phase 4
iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT03815019 is a Phase 4 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 70 participants.
The verdict
NCT03815019, a Phase 4 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a multi-center, randomized, placebo-controlled, double-blind clinical trial. The primary focus of the study is the evaluation of the effectiveness of treatment with megestrol as part of a 24 week behavioral feeding protocol in transitioning from tube to oral feedings in a pediatric population. Approximately 60 pediatric subjects matching the criteria for eligibility will be enrolled in the study and randomized to receive either megestrol (n=30) or placebo (n=30).
Interventions
- DRUG Megestrol Acetate
- BEHAVIORAL iKanEat Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2025-03-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03815019
The ClinicalTrials.gov registry entry for NCT03815019 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Megestrol Acetate is the first listed.
NCT03815019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03815019 about?
NCT03815019 is a clinical study titled "iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children". This is a multi-center, randomized, placebo-controlled, double-blind clinical trial. The primary focus of the study is the evaluation of the effectiveness of treatment with megestrol as part of a 24 week behavioral feeding protocol in transitioning from tube to oral feedings in a pediatric populatio...
What is the current status of trial NCT03815019?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2019-08-15. Estimated completion is 2025-03-19.
What interventions are being tested in trial NCT03815019?
The interventions under investigation include: Megestrol Acetate (DRUG), iKanEat Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03815019?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.